HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels

被引:58
作者
Annema, Wijtske [1 ,2 ]
Willemsen, Hendrik M. [3 ]
de Boer, Jan Freark [1 ]
Dikkers, Arne [1 ]
van der Giet, Markus [4 ]
Nieuwland, Wybe [3 ]
Kobold, Anneke C. Muller [5 ]
van Pelt, L. Joost [5 ]
Slart, Riemer H. J. A. [6 ,7 ]
van der Horst, Iwan C. C. [3 ]
Dullaart, Robin P. F. [8 ]
Tio, Rene A. [3 ,7 ]
Tietge, Uwe J. F. [1 ,2 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands
[2] Top Inst Food & Nutr, Wageningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[4] Charite Campus Benjamin Franklin, Div Nephrol & Endocrinol, Berlin, Germany
[5] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands
[6] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands
[7] Univ Groningen, Univ Med Ctr Groningen, Cardiovasc Imaging Grp Groningen, Groningen, Netherlands
[8] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands
关键词
Acute coronary syndrome; Cholesterol; Cholesterol efflux; HDL function; Inflammation; Oxidation; HIGH-DENSITY-LIPOPROTEIN; ANTIOXIDATIVE CAPACITY; INHIBITS; 3; MYELOPEROXIDASE; TRANSPORT; EXPRESSION; EFFLUX; STEPS; RISK;
D O I
10.1016/j.jacl.2016.08.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: High-density lipoproteins (HDLs) protect against the development of atherosclerotic cardiovascular disease. HDL function represents an emerging concept in cardiovascular research. OBJECTIVE: This study investigated the association between HDL functionality and acute myocardial infarction (MI) independent of HDL-cholesterol plasma levels. METHODS: Participants (non-ST-segment elevation MI, non-STEMI, n = 41; STEMI, n = 37; non MI patients, n = 33) from a prospective follow-up study enrolling patients with acute chest pain were matched for age and plasma HDL cholesterol. The in vitro capacity of HDL to (1) mediate cholesterol efflux from macrophage foam cells, (2) prevent low-density lipoprotein oxidation, and (3) inhibit TNF-alpha-induced vascular adhesion molecule-1 expression in endothelial cells was determined. RESULTS: STEMI-HDL displayed reduced cholesterol efflux (P<.001) and anti-inflammatory functionality (P=.001), whereas the antioxidative properties were unaltered. Cholesterol efflux correlated with the anti-inflammatory HDL activity (P<.001). Not C-reactive protein levels, a marker of systemic inflammation, but specifically plasma myeloperoxidase levels were independently associated with impaired HDL function (efflux: P=.022; anti-inflammation: P<.001). Subjects in the higher risk quartile of efflux (odds ratio [OR], 5.66; 95% confidence interval [CI], 1.26-25.00; P=.024) as well as anti-inflammatory functionality of HDL (OR, 5.53; 95% CI, 1.83-16.73; P=.002) had a higher OR for MI vs those in the three lower risk quartiles combined. CONCLUSION: Independent of plasma HDL cholesterol levels, 2 of 3 antiatherogenic HDL functionalities tested were significantly impaired in STEMI patients, namely cholesterol efflux and antiinflammatory properties. Increased myeloperoxidase levels might represent a major contributing mechanism for decreased HDL functionality in MI patients. (C) 2016 National Lipid Association. All rights reserved.
引用
收藏
页码:1318 / 1328
页数:11
相关论文
共 38 条
[1]   The HDL proteome in acute coronary syndromes shifts to an inflammatory profile [J].
Alwaili, Khalid ;
Bailey, Dana ;
Awan, Zuhier ;
Bailey, Swneke D. ;
Ruel, Isabelle ;
Hafiane, Anouar ;
Krimbou, Larbi ;
Laboissiere, Sylvie ;
Genest, Jacques .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2012, 1821 (03) :405-415
[2]   Regulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies [J].
Annema, Wijtske ;
Tietge, Uwe J. F. .
NUTRITION & METABOLISM, 2012, 9
[3]   Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A2 [J].
Annema, Wijtske ;
Nijstad, Niels ;
Toelle, Markus ;
de Boer, Jan Freark ;
Buijs, Ruben V. C. ;
Heeringa, Peter ;
van der Giet, Markus ;
Tietge, Uwe J. F. .
JOURNAL OF LIPID RESEARCH, 2010, 51 (04) :743-754
[4]   HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events [J].
Barter, Philip ;
Gotto, Antonio M. ;
LaRosa, John C. ;
Maroni, Jaman ;
Szarek, Michael ;
Grundy, Scott M. ;
Kastelein, John J. P. ;
Bittner, Vera ;
Fruchart, Jean-Charles .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (13) :1301-1310
[5]   Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease [J].
Besler, Christian ;
Heinrich, Kathrin ;
Rohrer, Lucia ;
Doerries, Carola ;
Riwanto, Meliana ;
Shih, Diana M. ;
Chroni, Angeliki ;
Yonekawa, Keiko ;
Stein, Sokrates ;
Schaefer, Nicola ;
Mueller, Maja ;
Akhmedov, Alexander ;
Daniil, Georgios ;
Manes, Costantina ;
Templin, Christian ;
Wyss, Christophe ;
Maier, Willibald ;
Tanner, Felix C. ;
Matter, Christian M. ;
Corti, Roberto ;
Furlong, Clement ;
Lusis, Aldons J. ;
von Eckardstein, Arnold ;
Fogelman, Alan M. ;
Luescher, Thomas F. ;
Landmesser, Ulf .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (07) :2693-2708
[6]   Prognostic value of myeloperoxidase in patients with chest pain [J].
Brennan, M ;
Penn, MS ;
Van Lente, F ;
Nambi, V ;
Shishehbor, MH ;
Aviles, RJ ;
Goormastic, M ;
Pepoy, ML ;
McErlean, ES ;
Topol, EJ ;
Nissen, SE ;
Hazen, SL .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (17) :1595-1604
[7]   Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome [J].
Cavusoglu, Erdal ;
Ruwende, Cyril ;
Eng, Calvin ;
Chopra, Vineet ;
Yanamadala, Sunitha ;
Clark, Luther T. ;
Pinsky, David J. ;
Marmur, Jonathan D. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (10) :1364-1368
[8]   HIGH-DENSITY-LIPOPROTEINS INHIBIT CYTOKINE-INDUCED EXPRESSION OF ENDOTHELIAL-CELL ADHESION MOLECULES [J].
COCKERILL, GW ;
RYE, KA ;
GAMBLE, JR ;
VADAS, MA ;
BARTER, PJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (11) :1987-1994
[9]   Inflammation reduces HDL protection against primary cardiac risk [J].
Corsetti, James P. ;
Gansevoort, Ron T. ;
Sparks, Charles E. ;
Dullaart, Robin P. F. .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 (06) :483-489
[10]   General cardiovascular risk profile for use in primary care - The Framingham Heart Study [J].
D'Agostino, Ralph B. ;
Vasan, Ramachandran S. ;
Pencina, Michael J. ;
Wolf, Philip A. ;
Cobain, Mark ;
Massaro, Joseph M. ;
Kannel, William B. .
CIRCULATION, 2008, 117 (06) :743-753